We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Blog

Releasing the Handbrake on Exosome Applications
Blog

Despite the great excitement about exosomes and their huge diagnostic and therapeutic potential, the technology needed to advance this work is lacking. We spoke to Jim West, CEO of Clara Biotech, who tells us how his team is working to fill that gap.

Read More

Automated Microfluidic Systems for Gene Editing
Blog

Recently, Oxford Genetics and Sphere Fluidics announced a multi-partner collaboration to expedite the development of automated microfluidic systems for rapid and high-throughput gene editing in mammalian cells. We spoke with Emily Leproust, PhD, CEO of Twist Biosciences, and other collaborators from the partnership to discuss the background of this announcement and the need for automated systems in gene editing.

Read More

Take a Good Book Around
Blog

Our recent social media poll on "book recommendations for scientists" provided an incredible response. We decided to collate this information and give you the perfect excuse to treat yourself to a new read. Enjoy!

Read More

The Vision for Multi-organ Human-on-a-Chip Models
Blog

The development of organ-on-a-chip models aims to reduce the (expensive) high drug failure rates that exist in clinical trials. A Florida biotech firm recently reported that their multi-organ “human-on-a-chip” system maintains cellular viability over 28 days in serum-free conditions, using a pumpless system. To learn more about the vision for multi-organ “human-on-a-chip” models, we caught up with James Hickman, Chief Science Officer of Hesperos Inc.

Read More

Is Off-the-Shelf Immunotherapy the Way Forward?
Blog

An “off-the-shelf” immuno-oncology product has been developed whereby T cells are derived from healthy donors, bypassing limitations related to high pricing and limited market access.

Read More

Tandem Mass Spectrometry: Rising to Challenges in Clinical Labs
Blog

Assay sensitivity and specificity continues to be a challenge in measuring hormones at low concentrations. Tandem mass spectrometry offers significant advantages - particularly in a clinical setting, where speed and sensitivity are required. Following SCIEX' launch of a new tandem mass spectrometry system, we spoke with Michael Jarvis, Product Manager at SCIEX, to find out more.

Read More

Entering the Golden Era of Lateral Flow Diagnostics
Blog

Gold nanorods are increasingly being used in diagnostic applications, such as lateral flow assays. To learn more, we got in touch with Darren Rowles, CEO of Sona Nanotech Inc. who provides insights on diagnostic industry trends, and tells us about the source, application and production process of gold nanoparticles.

Read More

Developing Stem Cell Therapy Solutions for Liver Disease
Blog

We spoke with Eric Schuur, President and CEO of HepaTx, to learn how the company hopes to develop regenerative medicine solutions for people with liver disease. Eric provides an overview of the steps involved in hepatocyte production and provides insights on the hurdles that need to be overcome, to get these stem cells from the lab to the clinic.

Read More

Sustainability Through Innovation
Blog

With growing pressure on labs to reduce waste and improve sustainability, we spoke to the Sustainability Forum at Agilent to learn more about what the company are doing to help their customers achieve their sustainability goals.

Read More

Designing Proteins Bit by Bit
Blog

Cell-Free Technology is taking a unique approach to protein technology with their BioBits initiative, which they say combines the ease of use of a digital design tool with the detailed scientific validation provided by a CRO. We catch up with Cell-Free CEO Tom Meany to discuss the new technology.

Read More